Case number 1:22-cv-01549
Janssen Biotech, Inc. v. Amgen Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 23, 2023 | 97 | SO ORDERED re 96 Stipulation and Order of Dismissal with Prejudice ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 5/23/2023. (dlw) (Entered: 05/23/2023) (3) |
| May 23, 2023 | 98 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,902,734; US 10,961,307. (Attachments: # 1 Stipulation of Dismissal)(as) (Entered: 05/23/2023) (0) |
| May 22, 2023 | 96 | STIPULATION of Dismissal with Prejudice by Janssen Biotech, Inc.. (Silver, Daniel) (Entered: 05/22/2023) (3) |
| May 15, 2023 | N/A | SO ORDERED re 95 STIPULATION TO EXTEND TIME for Amgen to file its answering brief in opposition to Janssen's motion for preliminary injunction to May 22, 2023 (Set Briefing Schedule: re 35 MOTION for Preliminary Injunction - Answering Brief due 5/22/2023). ORDERED by Judge Maryellen Noreika on 5/15/2023. (dlw) (Entered: 05/15/2023) (0) |
| May 12, 2023 | 95 | STIPULATION TO EXTEND TIME for Amgen to file its answering brief in opposition to Janssen's motion for preliminary injunction to May 22, 2023 - filed by Amgen Inc.. (Rawnsley, Jason) (Entered: 05/12/2023) (3) |
| May 9, 2023 | 94 | ORAL ORDER - Consistent with this Court's procedures, the parties contacted Chambers to request a teleconference date for an anticipated motion to strike and a discovery dispute, IT IS HEREBY ORDERED that this anticipated motion and discovery dispute are referred to Magistrate Judge Hatcher. The parties are directed to file Magistrate Judge Hatcher's "Motion for Teleconference to Resolve Discovery/Protective Order Disputes" which can be found at https://www.ded.uscourts.gov/judge/magistrate-judge-laura-d-hatcher, forms. ORDERED by Judge Maryellen Noreika on 5/9/2023. (dlw) (Entered: 05/09/2023) (0) |
| May 8, 2023 | 92 | NOTICE OF SERVICE of Defendant's Proposed Preliminary Claim Constructions and Identification of Intrinsic Evidence filed by Amgen Inc..(Rawnsley, Jason) (Entered: 05/08/2023) (3) |
| May 8, 2023 | 93 | NOTICE OF SERVICE of Plaintiff's Proposed Constructions for Terms to be Construed filed by Janssen Biotech, Inc..(Joyce, Alexandra) (Entered: 05/08/2023) (2) |
| May 4, 2023 | 90 | NOTICE OF SERVICE of Identification of Claim Terms for Construction filed by Janssen Biotech, Inc..(Joyce, Alexandra) (Entered: 05/04/2023) (2) |
| May 4, 2023 | 91 | NOTICE OF SERVICE of Defendant's Identification of Claim Terms/Phrases for Construction filed by Amgen Inc..(Rawnsley, Jason) (Entered: 05/04/2023) (3) |
| Apr 24, 2023 | N/A | SO ORDERED re 87 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Amended Complaint to May 24, 2023 (Set/Reset Answer Deadlines: Amgen Inc. answer due 5/24/2023). ORDERED by Judge Maryellen Noreika on 4/24/2023. (dlw) (Entered: 04/24/2023) (0) |
| Apr 24, 2023 | 88 | NOTICE to Take Deposition of Brian Carey on April 25, 2023 filed by Amgen Inc..(Mowery, Katharine) (Entered: 04/24/2023) (2) |
| Apr 24, 2023 | 89 | NOTICE to Take Deposition of Evan Wells on April 25, 2023 filed by Amgen Inc..(Mowery, Katharine) (Entered: 04/24/2023) (2) |
| Apr 21, 2023 | 87 | STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Amended Complaint to May 24, 2023 - filed by Amgen Inc.. (Mowery, Katharine) (Entered: 04/21/2023) (2) |
| Apr 18, 2023 | N/A | Pro Hac Vice Attorney Roger J. Chin for Janssen Biotech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 04/18/2023) (0) |
| Apr 17, 2023 | 86 | MOTION for Pro Hac Vice Appearance of Attorney Roger J. Chin - filed by Janssen Biotech, Inc.. (Joyce, Alexandra) (Entered: 04/17/2023) (3) |
| Apr 17, 2023 | N/A | SO ORDERED re 86 MOTION for Pro Hac Vice Appearance of Attorney Roger J. Chin filed by Janssen Biotech, Inc. ORDERED by Judge Maryellen Noreika on 4/17/2023. (dlw) (Entered: 04/17/2023) (0) |
| Apr 12, 2023 | 81 | NOTICE to Take Deposition of Holly Prentice, Ph.D. on April 17, 2023 filed by Amgen Inc..(Mowery, Katharine) (Entered: 04/12/2023) (3) |
| Apr 12, 2023 | 82 | NOTICE to Take Deposition of Brian Smith on April 18, 2023 filed by Amgen Inc. (Mowery, Katharine) Modified on 4/12/2023 (dlw). (Entered: 04/12/2023) (3) |
| Apr 12, 2023 | 83 | NOTICE to Take Deposition of Matthew S. Croughan, Ph.D. on April 20, 2023 filed by Amgen Inc..(Mowery, Katharine) (Entered: 04/12/2023) (3) |
| Apr 12, 2023 | 84 | NOTICE to Take Deposition of John C. Jarosz on April 20, 2023 filed by Amgen Inc..(Mowery, Katharine) (Entered: 04/12/2023) (3) |
| Apr 12, 2023 | 85 | NOTICE of Appearance by Jason James Rawnsley on behalf of Amgen Inc. (Rawnsley, Jason) (Entered: 04/12/2023) (2) |
| Apr 10, 2023 | 80 | NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendant's Notice of Rule 30(b)(6) Deposition filed by Janssen Biotech, Inc..(Joyce, Alexandra) (Entered: 04/10/2023) (2) |
| Mar 31, 2023 | 79 | NOTICE to Take Deposition of Janssen Biotech, Inc. on April 24, 2023 filed by Amgen Inc.. (Attachments: # 1 Schedule A)(Mowery, Katharine) (Entered: 03/31/2023) (0) |
| Mar 30, 2023 | 78 | REDACTED VERSION of 74 Exhibit to a Document, by Janssen Biotech, Inc.. (Joyce, Alexandra) (Entered: 03/30/2023) (2) |
| Mar 29, 2023 | 77 | NOTICE of Subpoena to Dr. Holly Prentice by Amgen Inc. (Attachments: # 1 Exhibit 1)(Mowery, Katharine) (Entered: 03/29/2023) (0) |
| Mar 24, 2023 | 76 | REDACTED VERSION of 69 Exhibit to a Document by Janssen Biotech, Inc. (Silver, Daniel) Modified on 3/24/2023 (dlw). (Entered: 03/24/2023) (2) |
| Mar 23, 2023 | 73 | REVISED STIPULATION and [Proposed] Discovery Plan and Schedule for Janssen's Preliminary Injunction Motion by Janssen Biotech, Inc. (Silver, Daniel) Modified on 3/23/2023 (dlw). (Entered: 03/23/2023) (5) |
| Mar 23, 2023 | 74 | [SEALED] EXHIBIT re 73 Stipulation and [Proposed] Discovery Plan and Schedule for Janssen's Preliminary Injunction Motion - Revised by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/23/2023 (dlw). (Entered: 03/23/2023) (0) |
| Mar 23, 2023 | 75 | SO ORDERED re 73 Revised Stipulation and Discovery Plan and Schedule for Janssen's Preliminary Injunction Motion (Set Briefing Schedule: re 35 MOTION for Preliminary Injunction - Answering Brief due 5/17/2023. Reply Brief due 6/26/2023. Surreplies due by 7/21/2023). ORDER Setting Hearing on Motion - A Motion Hearing is set for 8/4/2023 at 01:00 PM in Courtroom 4A before Judge Maryellen Noreika). Signed by Judge Maryellen Noreika on 3/23/2023. (dlw) (Entered: 03/23/2023) (5) |
| Mar 21, 2023 | 71 | NOTICE OF SERVICE of Janssen's Objections and Responses to Defendant Amgen Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-18) filed by Janssen Biotech, Inc..(Joyce, Alexandra) (Entered: 03/21/2023) (2) |
| Mar 21, 2023 | 72 | NOTICE OF SERVICE of Defendant Amgen Inc.'s Objections and Responses to Plaintiff's First Set of Requests for Production of Documents (Nos. 1-15) filed by Amgen Inc. (Pedi, Nicole) Modified on 3/22/2023 (dlw). (Entered: 03/21/2023) (2) |
| Mar 20, 2023 | 70 | ORAL ORDER re 68 Stipulation and Discovery Plan and Schedule for Janssen's Preliminary Injunction Motion - Having reviewed the parties' stipulation, IT IS HEREBY ORDERED that, if the parties want a decision by 10/31/2023, briefing must be complete by 7/21/2023. And, because the Court is allowing extra pages for the briefing, any claim construction issues must be addressed in the briefs. On or before 3/21/2023, the parties shall submit a revised stipulation for the Court's consideration. ORDERED by Judge Maryellen Noreika on 3/20/2023. (dlw) (Entered: 03/20/2023) (0) |
| Mar 17, 2023 | 68 | STIPULATION and [Proposed] Discovery Plan and Schedule for Janssen's Preliminary Injunction Motion by Janssen Biotech, Inc.. (Silver, Daniel) (Entered: 03/17/2023) (4) |
| Mar 17, 2023 | 69 | [SEALED] EXHIBIT re 68 Stipulation and [Proposed] Discovery Plan and Schedule for Janssen's Preliminary Injunction Motion by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/17/2023 (dlw). (Entered: 03/17/2023) (0) |
| Mar 15, 2023 | 59 | REDACTED VERSION of 25 Opening Brief in Support by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/15/2023 (dlw). (Entered: 03/15/2023) (30) |
| Mar 15, 2023 | 60 | REDACTED VERSION of 26 Declaration by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/15/2023 (dlw). (Entered: 03/15/2023) (14) |
| Mar 15, 2023 | 61 | REDACTED VERSION of 27 Exhibit to a Document by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/15/2023 (dlw). (Entered: 03/15/2023) (30) |
| Mar 15, 2023 | 62 | REDACTED VERSION of 28 Exhibit to a Document by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/15/2023 (dlw). (Entered: 03/15/2023) (2) |
| Mar 15, 2023 | 63 | REDACTED VERSION of 29 Exhibit to a Document by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/15/2023 (dlw). (Entered: 03/15/2023) (2) |
| Mar 15, 2023 | 64 | REDACTED VERSION of 30 Exhibit to a Document by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/15/2023 (dlw). (Entered: 03/15/2023) (30) |
| Mar 15, 2023 | 65 | REDACTED VERSION of 31 Declaration by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/15/2023 (dlw). (Entered: 03/15/2023) (30) |
| Mar 15, 2023 | 66 | REDACTED VERSION of 32 Declaration by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/15/2023 (dlw). (Entered: 03/15/2023) (14) |
| Mar 15, 2023 | 67 | REDACTED VERSION of 33 Declaration by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/15/2023 (dlw). (Entered: 03/15/2023) (30) |
| Mar 14, 2023 | 57 | NOTICE OF SERVICE of First Set of Requests for the Production of Documents and Things (Nos. 1-18) filed by Amgen Inc..(Pedi, Nicole) (Entered: 03/14/2023) (2) |
| Mar 14, 2023 | 58 | NOTICE OF SERVICE of Janssen's First Set of Requests for Production to Amgen Nos. 1-15 filed by Janssen Biotech, Inc..(Joyce, Alexandra) (Entered: 03/14/2023) (2) |
| Mar 13, 2023 | 48 | REDACTED VERSION of 36 Opening Brief in Support by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/14/2023 (dlw). (Entered: 03/13/2023) (25) |
| Mar 13, 2023 | 49 | REDACTED VERSION of 38 Exhibit to a Document by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/14/2023 (dlw). (Entered: 03/13/2023) (30) |
| Mar 13, 2023 | 50 | REDACTED VERSION of 39 Exhibit to a Document by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/14/2023 (dlw). (Entered: 03/13/2023) (2) |
| Mar 13, 2023 | 51 | REDACTED VERSION of 40 Exhibit to a Document by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/14/2023 (dlw). (Entered: 03/13/2023) (2) |
| Mar 13, 2023 | 52 | REDACTED VERSION of 41 Exhibit to a Document by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/14/2023 (dlw). (Entered: 03/13/2023) (30) |
| Mar 13, 2023 | 53 | REDACTED VERSION of 42 Declaration by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/14/2023 (dlw). (Entered: 03/13/2023) (30) |
| Mar 13, 2023 | 54 | REDACTED VERSION of 43 Declaration by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/14/2023 (dlw). (Entered: 03/13/2023) (14) |
| Mar 13, 2023 | 55 | REDACTED VERSION of 44 Declaration by Janssen Biotech, Inc. (Joyce, Alexandra) Modified on 3/14/2023 (dlw). (Entered: 03/13/2023) (30) |
| Mar 13, 2023 | 56 | REDACTED VERSION of 37 Appendix by Janssen Biotech, Inc.. (Joyce, Alexandra) (Entered: 03/13/2023) (11) |
| Mar 9, 2023 | 47 | MOTION for Pro Hac Vice Appearance of Attorney Wendy Whiteford and Drew Diamond - filed by Amgen Inc.. (Mowery, Katharine) (Entered: 03/09/2023) (3) |
| Mar 9, 2023 | N/A | SO ORDERED re 47 MOTION for Pro Hac Vice Appearance of Attorney Wendy Whiteford and Drew Diamond filed by Amgen Inc. ORDERED by Judge Maryellen Noreika on 3/9/2023. (dlw) (Entered: 03/09/2023) (0) |
| Mar 9, 2023 | N/A | Pro Hac Vice Attorney J. Drew Diamond for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 03/09/2023) (0) |
| Mar 7, 2023 | 46 | Amended Complaint* (1) |
| Mar 7, 2023 | 45 | STIPULATION and [Proposed] Order to Extend Deadline to File Redactions to Plaintiff's Preliminary Injunction Papers by Amgen Inc.. (Mowery, Katharine) (Entered: 03/07/2023) (3) |
| Mar 7, 2023 | N/A | SO ORDERED WITH MODIFICATION re 45 Stipulation and Order to Extend Deadline to File Redactions to Plaintiff's Preliminary Injunction Papers - IT IS HEREBY ORDERED that the stipulation is GRANTED-IN-PART. The redacted 3/1/2023 preliminary injunction papers shall be filed no later than 3/15/2023. ORDERED by Judge Maryellen Noreika on 3/7/2023. (dlw) (Entered: 03/07/2023) (0) |
| Mar 6, 2023 | 35 | MOTION for Preliminary Injunction - filed by Janssen Biotech, Inc.. (Attachments: # 1 Text of Proposed Order)(Silver, Daniel) (Entered: 03/06/2023) (0) |
| Mar 6, 2023 | 36 | [SEALED] OPENING BRIEF in Support re 35 MOTION for Preliminary Injunction filed by Janssen Biotech, Inc..Answering Brief/Response due date per Local Rules is 3/20/2023. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 03/06/2023) (0) |
| Mar 6, 2023 | 37 | [SEALED] APPENDIX re 36 Opening Brief in Support by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/7/2023 (dlw). (Entered: 03/06/2023) (0) |
| Mar 6, 2023 | 38 | [SEALED] EXHIBITS A1-A24 (Vol 1 of 4) re 37 Appendix by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/7/2023 (dlw). (Entered: 03/06/2023) (0) |
| Mar 6, 2023 | 39 | [SEALED] EXHIBITS A25-B12 (Vol 2 of 4) re 37 Appendix by Janssen Biotech, Inc. (Attachments: # 1 Volume 2 of 4 (Part 2 - B1-B12), # 2 Certificate of Service)(Silver, Daniel) Modified on 3/7/2023 (dlw). (Entered: 03/06/2023) (0) |
| Mar 6, 2023 | 40 | [SEALED] EXHIBITS B13-B22 (Vol 3 of 4) re 37 Appendix by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/7/2023 (dlw). (Entered: 03/06/2023) (0) |
| Mar 6, 2023 | 41 | [SEALED] EXHIBITS B23-C5 (Vol 4 of 4) re 37 Appendix by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/7/2023 (dlw). (Entered: 03/06/2023) (0) |
| Mar 6, 2023 | 42 | [SEALED] DECLARATION of Matthew S. Croughan, Ph.D. re 36 Opening Brief in Support by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/7/2023 (dlw). (Entered: 03/06/2023) (0) |
| Mar 6, 2023 | 43 | [SEALED] DECLARATION of Brian Smith re 36 Opening Brief in Support by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/7/2023 (dlw). (Entered: 03/06/2023) (0) |
| Mar 6, 2023 | 44 | [SEALED] DECLARATION of John C. Jarosz re 36 Opening Brief in Support by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/7/2023 (dlw). (Entered: 03/06/2023) (0) |
| Mar 2, 2023 | 34 | ORAL ORDER re 23 Stipulation and [Proposed] Order to Extend Page Limitations - IT IS HEREBY ORDERED that the Stipulation is DENIED. The request to extend page limits was filed seven minutes before the over-the-page limit brief was filed. The effect of this was that Plaintiff granted itself an extension without leave of Court and without respect for the Court and its rules. THEREFORE, IT IS FURTHER ORDERED that the 24 Motion for Preliminary Injunction is DENIED for failure to comply with the page limits. Counsel may re-file the motion with a brief that complies with the Court's rules. ORDERED by Judge Maryellen Noreika on 3/2/2023. (dlw) (Entered: 03/02/2023) (0) |
| Mar 1, 2023 | 23 | STIPULATION and [Proposed] Order to Extend Page Limitations by Janssen Biotech, Inc.. (Silver, Daniel) (Entered: 03/01/2023) (3) |
| Mar 1, 2023 | 24 | MOTION for Preliminary Injunction - filed by Janssen Biotech, Inc.. (Attachments: # 1 Text of Proposed Order)(Silver, Daniel) (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 25 | [SEALED] OPENING BRIEF in Support re 24 MOTION for Preliminary Injunction filed by Janssen Biotech, Inc..Answering Brief/Response due date per Local Rules is 3/15/2023. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 26 | [SEALED] DECLARATION of Cecilia Sanabria re 25 Opening Brief in Support by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/2/2023 (dlw). (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 27 | [SEALED] EXHIBITS (A1-A24) (Vol. 1 of 4) re 26 Declaration by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/2/2023 (dlw). (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 28 | [SEALED] EXHIBITS (A25-B12) (Vol. 2 of 4) re 26 Declaration by Janssen Biotech, Inc. (Attachments: # 1 Exhibits B1-B12, # 2 Certificate of Service)(Silver, Daniel) Modified on 3/2/2023 (dlw). (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 29 | [SEALED] EXHIBITS (B13-B22) (Vol. 3 of 4) re 26 Declaration by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/2/2023 (dlw). (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 30 | [SEALED] EXHIBITS (B23-C5) (Vol. 4 of 4) re 26 Declaration by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/2/2023 (dlw). (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 31 | [SEALED] DECLARATION of Matthew S. Croughan, Ph.D. re 25 Opening Brief in Support by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/2/2023 (dlw). (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 32 | [SEALED] DECLARATION of Brian Smith re 25 Opening Brief in Support by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/2/2023 (dlw). (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 33 | [SEALED] DECLARATION of John C. Jarosz re 25 Opening Brief in Support by Janssen Biotech, Inc. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 3/2/2023 (dlw). (Entered: 03/01/2023) (0) |
| Feb 28, 2023 | 22 | STIPULATION TO EXTEND TIME to File Redactions to March 7, 2023 - filed by Amgen Inc.. (Mowery, Katharine) (Entered: 02/28/2023) (2) |
| Feb 28, 2023 | N/A | SO ORDERED re 22 STIPULATION TO EXTEND TIME to File Redactions to March 7, 2023. ORDERED by Judge Maryellen Noreika on 2/28/2023. (dlw) (Entered: 02/28/2023) (0) |
| Feb 21, 2023 | 19 | STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 2/21/2023. (dlw) (Entered: 02/21/2023) (29) |
| Feb 21, 2023 | N/A | SO ORDERED re 18 STIPULATION TO EXTEND TIME to submit an Amended Complaint to February 21, 2023. ORDERED by Judge Maryellen Noreika on 2/21/2023. (dlw) (Entered: 02/21/2023) (0) |
| Feb 21, 2023 | 20 | [SEALED] First AMENDED COMPLAINT against Amgen Inc.- filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibits A - S, # 2 Exhibits T - WW, # 3 Exhibit XX, # 4 Redline Comparison, # 5 Certificate of Service)(Silver, Daniel) (Entered: 02/21/2023) (0) |
| Feb 21, 2023 | 21 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,902,734; 10,961,307; 8,852,889; 9,217,168; 9,475,858; 9,663,810. (Silver, Daniel) Modified on 2/22/2023 (dlw). (Entered: 02/21/2023) (1) |
| Feb 17, 2023 | 17 | PROPOSED ORDER // Stipulated Protective Order by Janssen Biotech, Inc. (Silver, Daniel) Modified on 2/21/2023 (dlw). (Entered: 02/17/2023) (30) |
| Feb 17, 2023 | 18 | STIPULATION TO EXTEND TIME to submit an Amended Complaint to February 21, 2023 - filed by Janssen Biotech, Inc.. (Silver, Daniel) (Entered: 02/17/2023) (2) |
| Feb 14, 2023 | N/A | Pro Hac Vice Attorney Kevin J. Perra for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 02/14/2023) (0) |
| Feb 13, 2023 | N/A | Pro Hac Vice Attorney Scott P. Cooper for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 02/13/2023) (0) |
| Feb 7, 2023 | N/A | Pro Hac Vice Attorney David M. Hanna for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/07/2023) (0) |
| Feb 7, 2023 | N/A | SO ORDERED re 16 MOTION for Pro Hac Vice Appearance of Attorney Dennis Smith, Alaina Whitt and James High filed by Amgen Inc. ORDERED by Judge Maryellen Noreika on 2/7/2023. (dlw) (Entered: 02/07/2023) (0) |
| Feb 7, 2023 | N/A | Pro Hac Vice Attorney James A. High and Siegmund Y. Gutman for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 02/07/2023) (0) |
| Feb 7, 2023 | N/A | Pro Hac Vice Attorney Dennis J. Smith and Alaina M. Whitt for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/07/2023) (0) |
| Feb 6, 2023 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Siegmund Y. Gutman, Scott P. Cooper, Kevin J. Perra, David Hanna, and Gourdin Sirles - filed by Amgen Inc.. (Mowery, Katharine) (Entered: 02/06/2023) (7) |
| Feb 6, 2023 | N/A | SO ORDERED re 15 MOTION for Pro Hac Vice Appearance of Attorney Siegmund Y. Gutman, Scott P. Cooper, Kevin J. Perra, David Hanna, and Gourdin Sirles filed by Amgen Inc. ORDERED by Judge Maryellen Noreika on 2/6/2023. (dlw) (Entered: 02/06/2023) (0) |
| Feb 6, 2023 | 16 | MOTION for Pro Hac Vice Appearance of Attorney Dennis Smith, Alaina Whitt and James High - filed by Amgen Inc.. (Mowery, Katharine) (Entered: 02/06/2023) (4) |
| Jan 30, 2023 | 14 | REDACTED VERSION of 9 Stipulation by Amgen Inc.. (Mowery, Katharine) (Entered: 01/30/2023) (2) |
| Jan 23, 2023 | 9 | [SEALED] STIPULATION Regarding Agreement As To US Patent No. 6,902,734 (B2) by Amgen Inc.. (Mowery, Katharine) (Entered: 01/23/2023) (0) |
| Jan 23, 2023 | 10 | PROPOSED ORDER to Stipulation Regarding As To US Patent No. 6,902,734 (B2)t re 9 Stipulation by Amgen Inc.. (Mowery, Katharine) (Entered: 01/23/2023) (1) |
| Jan 23, 2023 | 11 | SO ORDERED re 9 Stipulation Regarding Agreement as to U.S. Patent No. 6,902,734 (B2). Signed by Judge Maryellen Noreika on 1/23/2023. (dlw) (dlw). (Entered: 01/23/2023) (1) |
| Jan 23, 2023 | 12 | STIPULATION and [Proposed] Order Regarding Amended Complaint and Response by Amgen Inc.. (Mowery, Katharine) (Entered: 01/23/2023) (3) |
| Jan 23, 2023 | N/A | CORRECTING ENTRY: The signed Order has been uploaded to D.I. 11 and the NEF regenerated. (dlw) (Entered: 01/23/2023) (0) |
| Jan 23, 2023 | 13 | SO ORDERED WITH MODIFICATIONS re 12 Stipulation and Order Regarding Amended Complaint and Response. Signed by Judge Maryellen Noreika on 1/23/2023. (dlw) (Entered: 01/23/2023) (3) |
| Dec 20, 2022 | 8 | STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to January 23, 2023 - filed by Amgen Inc.. (Whetzel, Robert) (Entered: 12/20/2022) (2) |
| Dec 20, 2022 | N/A | SO ORDERED re 8 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to January 23, 2023 (Set/Reset Answer Deadlines: Amgen Inc. answer due 1/23/2023). ORDERED by Judge Maryellen Noreika on 12/20/2022. (dlw) (Entered: 12/20/2022) (0) |
| Dec 14, 2022 | 7 | MOTION for Pro Hac Vice Appearance of Attorney Michael A. Morin, David P. Frazier, Inge A. Osman, Cecilia Sanabria, Michael Seringhaus, and Gabrielle LaHatte - filed by Janssen Biotech, Inc.. (Joyce, Alexandra) (Entered: 12/14/2022) (9) |
| Dec 14, 2022 | N/A | SO ORDERED re 7 MOTION for Pro Hac Vice Appearance of Attorney Michael A. Morin, David P. Frazier, Inge A. Osman, Cecilia Sanabria, Michael Seringhaus, and Gabrielle LaHatte filed by Janssen Biotech, Inc. ORDERED by Judge Maryellen Noreika on 12/14/2022. (dlw) (Entered: 12/14/2022) (0) |
| Dec 14, 2022 | N/A | Pro Hac Vice Attorney Michael R. Seringhaus and Inge A. Osman for Janssen Biotech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 12/14/2022) (0) |
| Dec 7, 2022 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 12/07/2022) (0) |
| Dec 5, 2022 | 6 | SUMMONS Returned Executed by Janssen Biotech, Inc..Amgen Inc. served on 12/1/2022, answer due 12/22/2022. (Silver, Daniel) (Entered: 12/05/2022) (2) |
| Nov 29, 2022 | 1 | Complaint* (1) |
| Nov 29, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 11/30/2022) (3) |
| Nov 29, 2022 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,902,734 ;10,961,307. (vfm) (Entered: 11/30/2022) (1) |
| Nov 29, 2022 | 4 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc. filed by Janssen Biotech, Inc.. (vfm) (Entered: 11/30/2022) (2) |
| Nov 29, 2022 | 5 | Summons Issued as to Amgen Inc. on 11/30/2022. (vfm) (Entered: 11/30/2022) (2) |
